Moreover, silencing PRDM14 reduced the expression of CD44, which imparts cancer stemness [49], and STAT3, which is required for growth of CD44+CD24– stem cell-like breast cancer cells [50]. The gene discussed is CD44; the disease is breast carcinoma.